Canada markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.92-0.28 (-0.68%)
At close: 04:00PM EST
40.10 -0.82 (-2.00%)
After hours: 06:23PM EST
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2021-12-31
2020-12-31
2019-12-31
Total Revenue
875,484
810,456
729,264
1,122,599
Cost of Revenue
12,656
10,842
11,947
4,384
Gross Profit
862,828
799,614
717,317
1,118,215
Operating Expenses
Research Development
704,450
643,453
535,077
465,688
Selling General and Administrative
141,000
170,900
354,300
286,644
Total Operating Expenses
845,450
814,353
889,377
752,332
Operating Income or Loss
17,378
-14,739
-172,060
365,883
Interest Expense
3,100
4,300
44,990
48,768
Total Other Income/Expenses Net
2,357
-5,113
47,040
29,654
Income Before Tax
11,261
-29,148
-170,032
346,769
Income Tax Expense
3,940
-551
316,734
43,507
Income from Continuing Operations
7,321
-28,597
-486,766
303,262
Net Income
7,321
-28,597
-451,286
294,146
Net Income available to common shareholders
7,321
-28,597
-451,487
296,563
Basic EPS
-
-0.20
-3.23
2.12
Diluted EPS
-
-0.20
-3.23
2.08
Basic Average Shares
-
141,000
140,000
140,000
Diluted Average Shares
-
141,000
140,000
143,000
EBITDA
-
-5,288
-107,882
411,531